The identification of new biomarkers is an increasingly essential element of predictive, preventive and personalized medicine. To meet this need, The Biomarkers Consortium projects serve to develop and qualify promising biomarkers in order to help accelerate the delivery of successful new technologies, medicines and therapies for prevention, early detection, diagnosis and treatment of disease.
Working together, the members of the Biomarkers Consortium are building uniquely powerful collaborations that are increasing the development of biomarker-based technologies, medicines and therapies for the prevention, early detection, diagnosis and treatment of disease.
Biomarkers Consortium Goals:
Biomarkers Consortium Focus Areas:
The Biomarkers Consortium has established Steering Committees in four disease/therapeutic areas of focus:
The Consortium also develops and executes projects in other disease/therapeutic areas or in overarching areas directly through its Executive Committee.